Skip to main content
Clinical Trials/NCT03125512
NCT03125512CompletedNot Applicable

Comparing a Convenient Positional Therapy Device to CPAP for Treatment of Positional Obstructive Sleep Apnea, A Crossover Randomized Controlled Trial

Changi General Hospital1 site in 1 country41 target enrollmentStarted: February 27, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
41
Locations
1
Primary Endpoint
Epworth Sleepiness Scale ( ESS)

Study Overview

Brief Summary

This is a crossover randomized controlled trial comparing a convenient positional therapy (PT) device to continuous positive airway pressure (CPAP) in the treatment of positional obstructive sleep apnea (OSA).

Detailed Description

This study aims to compare a convenient positional therapy (PT) device used for 8 weeks to continuous positive airway pressure (CPAP) used for 8 weeks in patients with positional obstructive sleep apnea (OSA) in a crossover randomized controlled trial.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Research staff assessing the outcomes of the study, the scoring of the sleep studies, and data analyses will be blinded.

Eligibility Criteria

Ages
21 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age 21 years and above
  • •Epworth sleepiness scale 10 to 16
  • •No CPAP treatment or PT treatment for past 6 months
  • •A diagnosis of positional OSA based on a full in-laboratory overnight polysomnography with
  • •Total apnea/hypopnea index (AHI) >10 /hour and non-supine AHI < 10/hour
  • •Supine AHI greater than or equal to two times the non-supine AHI
  • •At least 15 minutes of supine and non-supine sleep

Exclusion Criteria

  • •Epworth sleepiness scale ≥17
  • •Commercial driving
  • •Unable or unwilling to use both treatments (CPAP and PT)
  • •Concurrent use of therapy for OSA such as mandibular advancement splints
  • •Conditions that preclude the ability to lie in a non-supine position, for example a shoulder injury
  • •Uncontrolled severe medical/psychiatric conditions such as severe chronic heart failure, malignancy.
  • •Patients with pacemaker
  • •Skin sensitivity around the neck and/or open wound around their neck

Arms & Interventions

Night Shift positional device

Experimental

Randomized to Night shift positional therapy first for 8 weeks, followed by CPAP for 8 weeks, with a 1 week washout period.

Intervention: Night Shift positional device (Device)

Continuous positive airway pressure

Active Comparator

Randomized to CPAP first for 8 weeks, followed by positional therapy for 8 weeks, with a 1 week washout period.

Intervention: continuous positive airway pressure (Device)

Outcomes

Primary Outcomes

Epworth Sleepiness Scale ( ESS)

Time Frame: 8 weeks after the beginning of each intervention

Difference in sleepiness ( PT minus CPAP) measured by the Epworth Sleepiness Scale ( ESS) after 8 weeks of device use

Secondary Outcomes

  • Functional Outcomes of Sleep Questionnaire ( FOSQ)(8 weeks after the beginning of each intervention)
  • Apnea-hypopnea Index ( AHI, events/hr)(8 weeks after the beginning of each intervention)
  • 36-Item Short Form Survey (SF-36)(8 weeks after the beginning of each intervention)
  • Patient preference(Upon study completion at week 17)
  • Patient adherence ( hours of device use per night)(8 weeks after the beginning of each intervention)
  • Pittsburgh Sleep Quality Index (PSQI)(8 weeks after the beginning of each intervention)
  • DASS21 questionnaire(8 weeks after the beginning of each intervention)
  • Oxygen desaturation index (3%) and lowest oxygen saturation ( %)(8 weeks after the beginning of each intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials